Literature DB >> 22553696

Bilateral scleromalacia perforans and peripheral corneal thinning in Wegener's granulomatosis.

S C Reddy1, I Tajunisah, T Rohana.   

Abstract

A rare case of bilateral scleromalacia perforans, bilateral peripheral corneal thinning (contact lens cornea) and unilateral orbital inflammatory disease in a 50 year old female patient with an indolent form Wegener's granulomatosis(WG) involving lungs and sinuses is reported. The patient survived for 12 years after the initial diagnosis of systemic disease. There was perforation of left globe following trauma and no perforation of the right globe till the last follow up of the patient.

Entities:  

Keywords:  Wegener's granulomatosis; peripheral thinning of cornea; proptosis; scleromalacia perforans

Year:  2011        PMID: 22553696      PMCID: PMC3340864          DOI: 10.3980/j.issn.2222-3959.2011.04.22

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  13 in total

1.  Corneal autoimmunity in patients with peripheral ulcerative keratitis (PUK) in association with rheumatoid arthritis and Wegener's granulomatosis.

Authors:  S L John; K Morgan; A B Tullo; P J Holt
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

Review 2.  Wegener's granulomatosis.

Authors:  L E Harman; C E Margo
Journal:  Surv Ophthalmol       Date:  1998 Mar-Apr       Impact factor: 6.048

3.  Peripheral corneal degeneration and occlusive vasculitis in Wegener's granulomatosis.

Authors:  P Austin; W R Green; D C Sallyer; F B Walsh; H T Kleinfelter
Journal:  Am J Ophthalmol       Date:  1978-03       Impact factor: 5.258

4.  Ocular complications of Wegener's granulomatosis.

Authors:  C L Bullen; T J Liesegang; T J McDonald; R A DeRemee
Journal:  Ophthalmology       Date:  1983-03       Impact factor: 12.079

5.  Chronic cicatrizing conjunctivitis in a patient with ocular cicatricial pemphigoid and fatal Wegener granulomatosis.

Authors:  E Miserocchi; N K Waheed; S Baltatzis; C S Foster
Journal:  Am J Ophthalmol       Date:  2001-12       Impact factor: 5.258

6.  An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

Authors:  E Reinhold-Keller; N Beuge; U Latza; K de Groot; H Rudert; B Nölle; M Heller; W L Gross
Journal:  Arthritis Rheum       Date:  2000-05

7.  Wegener's granulomatosis: The ocular manifestations revisited.

Authors:  S A. Sadiq; C R. Jennings; N S. Jones; R N. Downes
Journal:  Orbit       Date:  2000-12

Review 8.  Wegener's granulomatosis: ophthalmic manifestations and management.

Authors:  Nima Pakrou; Dinesh Selva; Igal Leibovitch
Journal:  Semin Arthritis Rheum       Date:  2006-04       Impact factor: 5.532

Review 9.  The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature.

Authors:  B F Haynes; M L Fishman; A S Fauci; S M Wolff
Journal:  Am J Med       Date:  1977-07       Impact factor: 4.965

10.  Ocular manifestations of Wegener's granulomatosis. Analysis of nine cases.

Authors:  Jyotirmay Biswas; Kalpana Babu; Lingam Gopal; Subramanian Krishnakumar; Sankarasubaiyan Suresh; Subramaniam Ramakrishnan
Journal:  Indian J Ophthalmol       Date:  2003-09       Impact factor: 1.848

View more
  3 in total

Review 1.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

2.  Atypical Granulomatosis with Polyangiitis Presenting with Meibomitis, Scleritis, Uveitis and Papillary Bladder Tumor: A Case Report and Literature Review.

Authors:  Takashi Kojima; Murat Dogru; Eisuke Shimizu; Hiroyuki Yazu; Aya Takahashi; Jun Shimazaki
Journal:  Diagnostics (Basel)       Date:  2021-04-09

3.  Scleromalacia perforans: a case report.

Authors:  Muhammad Ishaq Ghauri; Syeda Urooj Riaz; Amir Husain; Asad Raza Jafri; Zara Tul Ain Bashir
Journal:  J Med Case Rep       Date:  2018-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.